TRIPLIAM 5 mg /1,25 Mg/5 Mg Tabletki Powlekane

Treść ulotki

1. Tripliam 5 mg/1.25 mg/5 mg film-coated tablets, 5 mg/1.25 mg/10 mg film-coated tablets, 10 mg/2.5 mg/5 mg film-coated tablets, 10 mg/2.5 mg/10 mg film-coated tablets
   1. What is Tripliam and what is it used for
   2. What you need to know before taking Tripliam
   3. How to take Tripliam
   4. Possible side effects
   5. How to store Tripliam
   6. Package contents and other information

Tripliam 5 mg/1.25 mg/5 mg film-coated tablets, 5 mg/1.25 mg/10 mg film-coated tablets, 10 mg/2.5 mg/5 mg film-coated tablets, 10 mg/2.5 mg/10 mg film-coated tablets

perindopril arginine/indapamide/amlodipine

Read this leaflet carefully before you start taking this medicine as it contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it may be harmful.
• If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Contents of this leaflet:

• 1. What Tripliam is and what it is used for
• 2. What you need to know before you take Tripliam
• 3. How to take Tripliam
• 4. Possible side effects
• 5. How to store Tripliam
• 6. Contents of the pack and other information

1. What is Tripliam and what is it used for

Tripliam is a combination of three active ingredients: perindopril, indapamide and amlodipine. It is a
antihypertensive medicine used in the treatment of high blood pressure (hypertension).
Patients who are already taking the fixed combination of perindopril/indapamide and amlodipine in the form of
separate tablets can instead take a Tripliam tablet containing the three active ingredients at the
same dosage.
Each active ingredient lowers blood pressure and, together, they work to control it:

• Perindopril belongs to a class of drugs called Angiotensin Converting Enzyme (ACE) inhibitors. These drugs work by widening blood vessels, which makes it easier for the heart to pump blood through them.
• Indapamide is a diuretic (which belongs to a class of medicines called sulfonamide derivatives with an indolic ring). Diuretics increase the amount of urine produced by the kidneys. However, indapamide differs from other diuretics in that it causes only a slight increase in the amount of urine produced.
• Amlodipine is a calcium channel blocker (which belongs to the class of medicines called dihydropyridines). It works by relaxing blood vessels so that it is easier for blood to flow through them.

2. What you need to know before taking Tripliam

Do not take Tripliam

• if you are allergic to perindopril or to any other ACE inhibitor, to indapamide or to any other sulfonamide, to amlodipine or to other dihydropyridines, or to any of the other components of this medicine (listed in section 6),
• if you have experienced symptoms such as wheezing, swelling of the face or tongue, intense itching or severe skin rashes related to a previous treatment with ACE inhibitors or if you or a family member has experienced such symptoms in any other circumstance (condition called angioedema),
• if you have a severe liver disease or if you suffer from a condition called hepatic encephalopathy (a brain disease caused by a liver disease),
• if you suspect you have decompensated heart failure (severe fluid retention, difficulty breathing),
• if you have a narrowing of the aortic heart valve (aortic stenosis) or cardiogenic shock (a condition in which the heart is unable to provide enough blood to the body),
• if you suffer from heart failure following a heart attack,
• if you have severely low blood pressure (hypotension),
• if you have a decrease in potassium levels in the blood,
• if you suffer from a severe kidney disease where the blood flow to the kidneys is reduced (renal artery stenosis),
• if you are undergoing dialysis or any type of blood filtration. Depending on the machine used, therapy with Tripliam may not be suitable for you,
• if you have moderate kidney problems (for Tripliam dosages containing 10 mg/2.5 mg/5 mg and 10 mg/2.5 mg/10 mg),
• if you are pregnant for more than three months (it is best to avoid Tripliam even in the early stages of pregnancy) (see “Pregnancy and breastfeeding”),
• if you suffer from diabetes or your kidney function is impaired and you are being treated with a medicine that lowers blood pressure, containing aliskiren,
• if you are being treated with sacubitril/valsartan, a medicine used to treat heart failure (see “Warnings and precautions” and “Other medicines and Tripliam”).

Warnings and precautions
Talk to your doctor or pharmacist before using Tripliam:

• if you have hypertrophic cardiomyopathy (heart muscle disease) or renal artery stenosis (narrowing of the artery that supplies blood to the kidneys),
• if you suffer from other heart or kidney problems,
• if you suffer from a severe increase in blood pressure (hypertensive crisis),
• if you have liver problems,
• if you suffer from a collagen disease (skin disease) such as systemic lupus erythematosus or scleroderma,
• if you suffer from atherosclerosis (hardening of the arteries),
• if you need to undergo a test to check the functioning of the parathyroid gland,
• if you suffer from gout,
• if you have diabetes,
• if you are following a diet that limits salt intake or use salt substitutes containing potassium (a well-balanced blood potassium level is essential),
• if you are taking lithium or potassium-sparing diuretics (spironolactone, triamterene), as their use with Tripliam must be avoided (see “Other medicines and Tripliam”),
• if you are elderly and your dosage may need to be increased,
• if you have had photosensitivity reactions,
• if you are of Black ethnicity you may have a higher incidence of angioedema (swelling of the face, lips, mouth, tongue or throat that can cause difficulty swallowing or breathing) and a lesser effect in lowering blood pressure,
• if you are a patient undergoing hemodialysis with high-flux membranes,
• if you have kidney problems or are undergoing dialysis,
• if you experience a decrease in vision or eye pain. These may be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase in pressure in the eye and can occur within hours or weeks of taking Tripliam. This can lead to permanent vision loss if not treated. If you have previously had an allergy to penicillin or sulfonamides, you may be at greater risk of developing it,
• if you suffer from muscle disorders including muscle pain, tenderness, weakness or cramps,
• if you have an abnormally high level of an hormone called aldosterone in the blood (primary aldosteronism),
• if you have too much acid in the blood, which can cause rapid breathing,
• if you have cerebral circulatory insufficiency (low blood pressure in the brain),
• if you have swelling of the face, lips, mouth, tongue or throat that can cause difficulty swallowing or breathing (angioedema), which can occur at any time during treatment, immediately stop treatment and call your doctor,
• if you are taking any of the following medicines, increases the risk of angioedema:
• racecadotril (used to treat diarrhea),
• sirolimus, everolimus, temsirolimus and other medicines belonging to the class of so-called mTOR inhibitors (used in preventing rejection following transplantation,
• sacubitril (available as a fixed-dose combination with valsartan), used in the long-term treatment of heart failure.
• if you are taking any of the following medicines used to treat high blood pressure:
• an "angiotensin II receptor antagonist" (AIIRA) (also known as sartans - for example valsartan, telmisartan, irbesartan), especially if you suffer from kidney problems related to diabetes,
• aliskiren. Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals. See also what is reported under "Do not take Tripliam".

Your doctor may prescribe blood tests to check low levels of sodium or potassium or high levels
of calcium.
You must tell your doctor if you think you are pregnant (or if there is a possibility of becoming
pregnant). Tripliam is not recommended in early pregnancy, and must not be taken if you are
pregnant for more than three months, as it can cause serious harm to the baby if taken during this
period (see “Pregnancy and breastfeeding”).
If you are taking Tripliam, tell your doctor or medical staff:

• if you need to undergo anesthesia and/or surgery,
• if you have recently had diarrhea or vomiting, or if you are dehydrated,
• if you need to undergo dialysis or LDL apheresis (blood purification from cholesterol by means of a machine),
• if you need to undergo desensitization treatment to reduce the effects of allergy to bee or wasp stings,
• if you need to undergo a medical examination that requires the injection of an iodinated contrast agent (a substance that makes organs such as kidneys or stomach visible on X-rays). For those who play sports: the use of the drug without a therapeutic need constitutes doping and may still result in a positive doping test.

Children and adolescents
Tripliam should not be given to children and adolescents.

Other medicines and Tripliam
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicines.
Do not take aliskiren (used to treat high blood pressure) if you have diabetes or if you suffer from
kidney problems.
Do not take Tripliam with:

• lithium (used to treat some mental health disorders such as mania, manic depression and recurrent depression),
• potassium-sparing diuretics (such as triamterene, amiloride), potassium supplements or salt substitutes containing potassium, other medicines that can increase potassium levels in the blood (such as heparin and co-trimoxazole, also known as trimethoprim/sulfamethoxazole),
• dantrolene (infusion), also used to treat malignant hyperthermia during anesthesia (symptoms include very high fever and muscle stiffness),
• estramustine (used in cancer therapy),
• medicines used mainly for the treatment of diarrhea (racecadotril) or for the prevention of rejection after organ transplantation (sirolimus, everolimus, temsirolimus and other medicines belonging to the class of so-called mTOR inhibitors). See section “Warnings and precautions”,
• sacubitril/valsartan (used for the long-term treatment of heart failure). See what is reported under "Do not take Tripliam” and “Warnings and precautions”,
• other medicines used to treat high blood pressure: angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Treatment with Tripliam may be affected by other medicines. Your doctor may need to
adjust the dose and/or take other precautions. Make sure to tell your doctor if you are taking any
of the following medicines as special attention may be required:

• other medicines for the treatment of hypertension, including an angiotensin II receptor antagonist (AIIRA), aliskiren (see also what is reported under “Do not take Tripliam” and “Warnings and precautions”) or diuretics (medicines that increase the amount of urine produced by the kidneys),
• potassium-sparing diuretics used in the treatment of heart failure: eplerenone and spironolactone at doses between 12.5 mg and 50 mg per day,
• anesthetics,
• iodinated contrast agents,
• bepridil (used in the treatment of angina pectoris),
• methadone (used for the treatment of addictions),
• medicines used to treat heart rhythm problems (e.g. dofetilide, ibutilide, bretylium, cisapride, difemamile, procainamide, quinidine, hydroquinidine, disopyramide, amiodarone, sotalol,
• verapamil, diltiazem (heart medicines),
• digoxin and other cardiac glycosides (for the treatment of heart problems),
• antibiotics used to treat bacterial infections (e.g. rifampicin, erythromycin, clarithromycin, sparfloxacin, moxifloxacin),
• antifungal medicines (e.g. itraconazole, ketoconazole, amphotericin B injection),
• allopurinol (for the treatment of gout),
• antihistamines used to treat allergic reactions, such as hay fever (e.g. mizolastine, terfenadine or astemizole),
• corticosteroids used to treat various conditions including severe asthma and rheumatoid arthritis, and non-steroidal anti-inflammatory drugs (e.g. ibuprofen) or salicylates at high doses (e.g. acetylsalicylic acid (aspirin)),
• immunosuppressants (medicines used to control the body's immune response) for the treatment of autoimmune diseases or after an organ transplant (e.g. cyclosporine, tacrolimus),
• tetracosactide (for the treatment of Crohn's disease),
• gold salts, especially for intravenous administration (used to treat the symptoms of rheumatoid arthritis),
• alofrantine (used to treat some types of malaria),
• baclofen used to treat muscle stiffness in diseases such as multiple sclerosis,
• medicines for the treatment of diabetes such as insulin or metformin,
• calcium including calcium supplements,
• stimulant laxatives (e.g. senna),
• medicines for the treatment of cancer,
• vincamine (used to treat symptomatic cognitive disorders in the elderly including memory loss),
• medicines used to treat mental health disorders such as depression, anxiety, schizophrenia (e.g. tricyclic antidepressants, antipsychotics, imipramine-like antidepressants, neuroleptics (such as amisulpride, sulpiride, sultopride, tiapride, haloperidol, droperidol)),
• pentamidine (used to treat pneumonia),
• ritonavir, indinavir, nelfinavir (so-called protease inhibitors used to treat HIV),
• hypericum perforatum (St. John's wort),
• trimethoprim (for the treatment of infections),
• medicines used to treat low blood pressure, shock or asthma (e.g. ephedrine, norepinephrine or adrenaline),
• nitroglycerin and other nitrates, or other vasodilators that can further reduce blood pressure.

Tripliam with food and drink
People taking Tripliam should not drink grapefruit juice or eat grapefruit, as
grapefruit and its juice can induce an increase in the levels of the active ingredient amlodipine in the
blood, which can lead to an unquantifiable increase in the hypotensive effect of Tripliam.

Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning to become pregnant, ask your doctor or
pharmacist for advice before using this medicine.
Pregnancy
You must tell your doctor if you think you are pregnant (or if there is a possibility of becoming
pregnant). As a rule, your doctor will advise you to stop taking Tripliam before starting
pregnancy or as soon as you find out you are pregnant and will advise you to take another
medicine instead of Tripliam.
Tripliam is not recommended in early pregnancy, and must not be taken if you are
pregnant for more than three months, as it can cause serious harm to the baby if taken after the third month of
pregnancy.

Breastfeeding
Tell your doctor if you are breastfeeding or are planning to start breastfeeding.
Tripliam is not recommended for women who are breastfeeding, and your doctor may choose another
treatment if you wish to breastfeed, especially if your baby is newly born or premature.

Driving and operating machinery
Tripliam may have an effect on the ability to drive or operate machinery. If the tablets cause you
to feel unwell, dizzy or fatigued, or if they cause headache, avoid driving or operating machinery and contact
your doctor immediately.

Tripliam contains sodium
Tripliam contains less than 1 mmol of sodium (23mg) per tablet, i.e. it is essentially "sodium-free"

3. How to take Tripliam

Use this medicine following exactly the instructions of your doctor or pharmacist. If you have any doubts
consult your doctor or pharmacist.
The tablet should be swallowed with a glass of water, preferably in the morning and before a meal.
The doctor will decide the correct dose for you. The usual dose is one tablet a day.

If you take more Tripliam than you should
If you take an excessive number of tablets, your blood pressure may drop, even excessively, and
this may constitute a danger, sometimes associated with nausea, vomiting, cramps, dizziness, drowsiness,
mental confusion, oliguria (less urine output than normal), anuria (no urine production or
passage of urine). You may feel dizzy, weak or faint. The drop in blood pressure may be so
severe as to cause you to go into shock. Your skin may become cold and clammy and you may
lose consciousness. If you have taken an excessive number of Tripliam tablets, contact your doctor immediately .
If you forget to take Tripliam
It is important to take the medicine every day as regular treatment is more effective. However, if you
forget to take a dose of Tripliam, take the next dose as usual. Do not take a
double dose to compensate for a missed dose.

If you stop taking Tripliam
Because treatment with Tripliam for hypertension is usually lifelong, you should talk to your doctor before
stopping taking this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
manifest.

If you experience any of the following serious effects, stop taking the medicine immediately and contact
your doctor immediately:

• sudden onset of shortness of breath, chest pain, wheezing or difficulty breathing (uncommon) (less than 1 in 100)
• swelling of the eyelids, face or lips (uncommon) (less than 1 in 100)
• swelling of the mouth, tongue and throat which can cause severe difficulty breathing (uncommon) (less than 1 in 100)
• severe skin reactions including intense rash, hives, widespread skin redness, severe itching, blisters, peeling and swelling of the skin, inflammation of the mucous membranes (Stevens Johnson syndrome, Toxic Epidermal Necrolysis) or other allergic reactions (very rare) (less than 1 in 10,000)
• severe dizziness or fainting (common) (less than 1 in 10)
• myocardial infarction (heart attack), (very rare) (less than 1 in 10,000), irregular heartbeat that could be life-threatening (not known)
• inflammation of the pancreas which can cause severe abdominal and back pain accompanied by a feeling of severe malaise (very rare) (less than 1 in 10,000).
• Muscle weakness, cramps, soreness or pain and in particular, if at the same time, you do not feel well or have a high fever, this may be caused by abnormal muscle breakdown (not known).

In decreasing order of frequency, side effects may include:

• Very common (may affect more than 1 in 10 people): edema (fluid retention).
• Common (may affect up to 1 in 10 people): headache, dizziness, palpitations (awareness of your heartbeat), hot flushes, vertigo, tingling, impaired vision, double vision, tinnitus (sensation of noise in the ears), lightheadedness due to a drop in pressure, cough, shortness of breath, gastrointestinal disorders (nausea, vomiting, abdominal pain, taste disturbances, dyspepsia or indigestion, diarrhea, constipation, changes in bowel habits), allergic reactions (such as skin rashes, itching), muscle spasms, feeling tired, weakness, drowsiness, swelling of the ankles.
• Uncommon (may affect up to 1 in 100 people): mood changes, anxiety, depression, sleep disorders, tremors, hives, fainting, loss of pain sensation, irregular and/or rapid heartbeat, rhinitis (blocked or runny nose), hair loss, purpura (red spots on the skin), skin discoloration, skin itching, sweating, chest pain, pain in joints or muscles, back pain, pain,

feeling unwell, kidney problems, problems with passing urine, increased need to urinate
at night, increased number of times passing urine, impotence, fever or high temperature, discomfort
or enlargement of the breasts in men, increase or decrease in weight, increased white blood cells, high
plasma potassium levels, hypoglycemia (very low blood sugar levels), low sodium
blood levels, vasculitis (inflammation of blood vessels), photosensitivity reaction (changes
in skin appearance) after exposure to sunlight or artificial UVA, clusters of blisters on the skin,
swelling of hands or feet, increased plasma creatinine and increased plasma urea, falls,
dry mouth.

• Rare (may affect up to 1 in 1,000 people): confused state, changes in laboratory parameters: increased levels of liver enzymes, high serum bilirubin levels and worsening of psoriasis.
• Very rare (may affect up to 1 in 10,000 people): Decreased number of white blood cells, decreased number of platelets in the blood (which may result in unusual bruising or a tendency to bleed), anemia (decreased red blood cells), angina pectoris (chest, jaw and back pain, caused by physical exertion, and due to problems with blood flow to the heart), eosinophilic pneumonia (a rare type of pneumonia), swelling of the gums, severe skin reactions including intense rash, redness of the skin all over the body, severe itching, blisters, peeling or swelling of the skin, erythema multiforme (a rash that often starts with itchy red spots on the face, arms and legs), bleeding, soft or enlarged gums, abnormal liver function, inflammation of the liver (hepatitis), severe kidney problems, yellowing of the skin (jaundice), abdominal swelling (gastritis), nerve diseases that can cause weakness, tingling or numbness, increased muscle tension, hyperglycemia (very high blood sugar levels), high blood calcium levels, stroke possibly secondary to excessive decrease in blood pressure.
• Not known (frequency cannot be estimated from the available data): Hepatic encephalopathy (brain disease caused by liver disease), abnormal ECG heart tracing, low potassium levels in the blood, if you suffer from systemic lupus erythematosus (a connective tissue disease), this may worsen. Myopia, blurred vision, decreased vision or eye pain due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma). Tremors, postural rigidity, mask-like face, slow movements, unbalanced and shuffling gait. Abnormal color, numbness and pain in the fingers of the hands or feet (Raynaud's phenomenon). Changes in laboratory parameters (blood tests) may occur. Your doctor may prescribe you laboratory tests to check your condition

With the use of ACE inhibitors, highly concentrated urine (dark in color), feeling or
state of malaise, muscle cramps, confusion and convulsions may occur, probably due to inappropriate
secretion of ADH (antidiuretic hormone). If you experience these symptoms, seek immediate medical
attention.

Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. You can also report side effects directly through the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse .
By reporting side effects you can help provide more information on the safety of
this medicine.

5. How to store Tripliam

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the package and on the container. The expiry date
refers to the last day of that month.
This medicine does not require any special storage conditions.
For the container with 28 and 30 film-coated tablets, the stability of use after first opening is
30 days.
For the container with 100 film-coated tablets, the stability of use after first opening is 100
days.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to eliminate
medicines that you no longer use. This will help protect the environment.

6. Package contents and other information

What Tripliam contains

• The active ingredients are perindopril arginine, indapamide and amlodipine. One film-coated Tripliam 5/1.25/5 mg tablet contains 3.395 mg of perindopril equivalent to 5 mg of perindopril arginine, 1.25 mg of indapamide and 6.935 mg of amlodipine besilate equivalent to 5 mg of amlodipine. One film-coated Tripliam 5/1.25/10 mg tablet contains 3.395 mg of perindopril equivalent to 5 mg of perindopril arginine, 1.25 mg of indapamide and 13.870 mg of amlodipine besilate equivalent to 10 mg of amlodipine. One film-coated Tripliam 10/2.5/5 mg tablet contains 6.790 mg of perindopril equivalent to 10 mg of perindopril arginine, 2.5 mg of indapamide and 6.935 mg of amlodipine besilate equivalent to 5 mg of amlodipine. One film-coated Tripliam 10/2.5/10 mg tablet contains 6.790 mg of perindopril equivalent to 10 mg of perindopril arginine, 2.5 mg of indapamide and 13.870 mg of amlodipine besilate equivalent to 10 mg of amlodipine.

The other ingredients are:

• Core: Calcium carbonate starch compound: Calcium carbonate 90%, Pregelatinized corn starch 10%, microcrystalline cellulose (E460), sodium croscarmellose (E468), magnesium stearate (E572), anhydrous colloidal silica, pregelatinized starch.
• Film coating: Glycerol (E422), hypromellose 6 mPa.s (E464), macrogol 6000, magnesium stearate (E572), titanium dioxide (E171).

Description of the appearance of Tripliam and package contents
Tripliam 5/1.25/5 mg: film-coated tablet, white, oblong, 9.75 mm long and 5.16 mm wide, engraved with

on the other side.
Tripliam 5/1.25/10 mg: film-coated tablet, white, oblong, 10.7 mm long and 5.66 mm wide, engraved with
on one side and

on the other side.
Tripliam 10/2.5/5 mg: film-coated tablet, white, oblong, 11.5 mm long and 6.09 mm wide, engraved with
on one side and

on the other side.
Tripliam 10/2.5/10 mg: film-coated tablet, white, oblong, 12.2 mm long and 6.46 mm wide, engraved with
on one side and

on the other side.
The tablets are available in boxes of 10, 28, 30, 60 (2 containers of 30 tablets), 84 (3 containers of 28 tablets), 90 (3 containers of 30 tablets), 100, 500 tablets (5 containers of 100 tablets).
A desiccant is present in the cap of the tablet containers.
Not all pack sizes may be marketed.
on one side and

Marketing Authorisation Holder and Manufacturer
Les Laboratoires Servier
50, rue Carnot
92284 Suresnes Cedex
France
Sales representative for Italy
Servier Italia S.p.A.
Via Luca Passi, 85
00166 Rome
Italy

Manufacturers:
Servier (Ireland) Industries Ltd
Gorey Road
Arklow - Co. Wicklow – Ireland
and
Les Laboratoires Servier Industrie
905 route de Saran
45520 Gidy – France
and
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
03-236 Warszawa
ul. Annopol 6b – Poland
and
EGIS Pharmaceuticals PLC
H-9900 Körmend, Mátyás király u.65
Hungary

This medicinal product is authorised in the Member States of the European Economic Area with the following
denominations:
Belgium TRIPLIXAM, film-coated tablet
Bulgaria TRIPLIXAM, film-coated tablets
Cyprus
Czech Republic
TRIPLIXAM, επικαλυμμένα με λεπτό υμένιο δισκία
TRIPLIXAM
Croatia TRIPLIXAM, filmom obložene tablete
Estonia TRIPLIXAM
Finland TRIPLIXAM, kalvopäällysteinen tabletti
France TRIPLIXAM, comprimé pelliculé
Greece TRIPLIXAM, επικαλυμμένα με λεπτό υμένιο δισκία
Ireland COVERDINE film-coated tablets
Italy TRIPLIAM, film-coated tablets
Latvia TRIPLIXAM, apvalkotās tabletes
Lithuania TRIPLIXAM, plėvele dengtos tabletės
Luxembourg TRIPLIXAM, comprimé pelliculé
Malta TRIPLIXAM film-coated tablets
Netherlands TRIPLIXAM, filmomhulde tabletten
Poland TRIPLIXAM
Portugal TRIPLIXAM
Romania TRIPLIXAM comprimate filmate
Slovakia
Slovenia
TRIPLIXAM, filmom obalené tablety
TRIPLIXAM filmsko obložene tablete